New Haven Connecticut based Wellinks fka Convexity Scientific is raising $24,999,948.00 in New Equity Investment.
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Wellinks fka Convexity Scientific is raising $24,999,948.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Alex Waldron played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Wellinks fka Convexity Scientific
Wellinks is a COPD-focused digital health company fueled by a mission to empower people in their pursuit to breathe freely. Wellinks lead asset is a digitally enabled and outcomes-driven holistic virtual care management solution for COPD, with a focus on reinventing respiratory care. The companys expertise in COPD innovation began with the development and FDA 510(k) clearance of Flyp Nebulizer, the first truly pocket-portable nebulizer, allowing patients simple, convenient, and connected access to breathing treatments. Wellinks connects individuals and their caregivers through a suite of medical devices and intuitive software, enabling virtual COPD care management based on information that is real-time, accurate, and actionable.
To learn more about Wellinks fka Convexity Scientific, visit http://flypnebulizer.com/
Contact:
Alex Waldron, Chief Executive Officer
844-359-7632
https://www.linkedin.com/in/alexcwaldron/
SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved